148 related articles for article (PubMed ID: 15632451)
21. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
[TBL] [Abstract][Full Text] [Related]
22. Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy.
Vural F; Donmez A; Doganavşargil B; Cagýrgan S; Alper H; Tombuloglu M
Transfus Apher Sci; 2005 Oct; 33(2):129-33. PubMed ID: 16150645
[TBL] [Abstract][Full Text] [Related]
23. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
24. [Cutaneous manifestations of graft versus host reaction].
Aractingi S; Carosella ED; Gluckman E
Ann Dermatol Venereol; 1998 Sep; 125(9):620-7. PubMed ID: 9805557
[No Abstract] [Full Text] [Related]
25. Gastrointestinal chronic graft-versus-host disease: management options.
Awan F; Hamadani M
J Oncol Pharm Pract; 2007 Mar; 13(1):49-51. PubMed ID: 17621568
[TBL] [Abstract][Full Text] [Related]
26. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
[TBL] [Abstract][Full Text] [Related]
27. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
Schmook T; Kraft J; Benninghoff B; Nindl I; Roewert J; Ulrich C; Stockfleth E
Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
[No Abstract] [Full Text] [Related]
28. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
[TBL] [Abstract][Full Text] [Related]
29. Update on the management of acute graft-versus-host disease.
Bolaños-Meade J
Curr Opin Oncol; 2006 Mar; 18(2):120-5. PubMed ID: 16462179
[TBL] [Abstract][Full Text] [Related]
30. Open wound chronic skin graft-vs-host disease. Are these wounds ischemic?
Gassas A; Wayne Evans A; Armstrong C; Doyle JJ
Pediatr Transplant; 2007 Feb; 11(1):101-4. PubMed ID: 17239131
[TBL] [Abstract][Full Text] [Related]
31. Skin grafting: comparative evaluation of two dressing techniques in selected body areas.
De Gado F; Chiummariello S; Monarca C; Dessy LA; Rizzo MI; Alfano C; Scuderi N
In Vivo; 2008; 22(4):503-8. PubMed ID: 18712179
[TBL] [Abstract][Full Text] [Related]
32. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
Russo PA; Bouchard CS; Galasso JM
Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
[TBL] [Abstract][Full Text] [Related]
33. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation.
Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H
J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284
[TBL] [Abstract][Full Text] [Related]
34. The ideal split-thickness skin graft donor site dressing: rediscovery of polyurethane film.
Dornseifer U; Fichter AM; Herter F; Sturtz G; Ninkovic M
Ann Plast Surg; 2009 Aug; 63(2):198-200. PubMed ID: 19571740
[TBL] [Abstract][Full Text] [Related]
35. Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation.
Ritchie D; Seconi J; Wood C; Walton J; Watt V
Biol Blood Marrow Transplant; 2005 Sep; 11(9):706-12. PubMed ID: 16125641
[TBL] [Abstract][Full Text] [Related]
36. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
Komanduri KV; Couriel D; Champlin RE
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
[TBL] [Abstract][Full Text] [Related]
37. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management.
Zantomio D; Grigg AP; MacGregor L; Panek-Hudson Y; Szer J; Ayton R
Bone Marrow Transplant; 2006 Oct; 38(8):567-72. PubMed ID: 16953208
[TBL] [Abstract][Full Text] [Related]
38. Reversal of severe graft-versus-host disease after nonmyeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem cells.
Khan SA; Moreb JS
Bone Marrow Transplant; 2005 Aug; 36(3):267-8. PubMed ID: 15937501
[No Abstract] [Full Text] [Related]
39. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP
Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591
[TBL] [Abstract][Full Text] [Related]
40. Rituximab responsive refractory acute graft-versus-host disease.
Kamble R; Oholendt M; Carrum G
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1201-2. PubMed ID: 17085314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
